10/31/14 GS 189.99 Goldman Sachs Group $GS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
10/31/14 GS 189.99 Goldman Sachs Group $GS Hit a 52 week high of 190.00 Closing the day 10/31/14 at 189.99 +3.02 +1.62% With a day low of 188.12 and a total volume of 3,356,900.

GS Recent Posts: http://investorshangout.com/Goldman-Sachs-Group-GS-51203/

GS Goldman Sachs Group Recent Headline News

3 Warren Buffett Stocks We'd Buy Right Now
Motley Fool Staff - Motley Fool - Sat Nov 01, 11:02AM CDT
When choosing stocks to buy, it's tough to argue against investing alongside Warren Buffett. According to Berkshire Hathaway 's latest SEC filing, the company owns shares of 45 publicly traded companies. So, which are the best choices for...
KO: 41.88 (+0.48), V: 241.43 (+4.78), GS: 189.99 (+3.02), COF: 82.77 (+1.04), AXP: 89.95 (+1.21), C: 53.53 (+0.38), AAPL: 108.00 (+1.02), MA: 83.75 (+0.62)

'Fast Money' Recap: Will Japan's Stimulus Lead to U.S. Deflation?
at The Street - Sat Nov 01, 4:00AM CDT
The trading panel discussed the S&P 500, whether to buy Apple and if Kim Kardasian is the only thing Glu Mobile has going for it.
FDX: 167.40 (+2.11), HD: 97.52 (unch), C: 53.53 (+0.38), SNE: 19.82 (+1.10), BBY: 34.14 (+0.52), GLUU: 3.87 (+0.26), CELG: 107.09 (+0.15), DXJ: 53.82 (+3.33), SBUX: 75.56 (-1.76), GS: 189.99 (+3.02), EXPE: 84.97 (+4.24), AAPL: 108.00 (+1.02), CTRL: 15.51 (+1.84)

Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Leads The Day Higher, Wal-Mart Stores (WMT) Lags
at The Street - Fri Oct 31, 3:30PM CDT
The Dow component that led the way higher today was Goldman Sachs Group (NYSE:GS), which sported a $3.02 gain (+1.6%) bringing the stock to $189.99. Holding the Dow back today was Wal-Mart Stores (NYSE:WMT), which lagged the broader Dow index with an...
GS: 189.99 (+3.02), WMT: 76.27 (-0.18)

'Fast Money' Recap: A Strong Finish for October but Rally Not Done
at The Street - Fri Oct 31, 1:25PM CDT
Investors should use some caution moving forward, but the rally in U.S. stocks doesn't appear to be finished.
GPRO: 77.10 (+8.85), F: 14.09 (+0.14), C: 53.53 (+0.38), BAC: 17.16 (+0.13), TLT: 119.25 (-0.31), HPQ: 35.88 (+0.56), MS: 34.95 (+0.43), SBUX: 75.56 (-1.76), VLO: 50.09 (+1.24), GT: 24.23 (+0.69), SPY: 201.66 (+2.28), GS: 189.99 (+3.02), QQQ: 101.40 (+1.38), ESV: 40.59 (+0.64), DIA: 173.45 (+1.85), GM: 31.40 (+0.62), IWM: 116.56 (+1.69), GRPN: 7.31 (+1.32)

Dow 30 Stock Roundup: DuPont, Merck, Pfizer Beat Estimates - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Oct 31, 10:41AM CDT
The Dow experienced gains every day of the week, but for Wednesday, boosted by positive economic data and bullish earnings results.
MMM: 153.77 (+1.67), GS: 189.99 (+3.02), V: 241.43 (+4.78), IBM: 164.40 (+0.05), MRK: 57.94 (+0.63), PFE: 29.95 (+0.11), DD: 69.15 (+1.49), CAT: 101.41 (+1.25), PG: 87.27 (+0.33), MSFT: 46.95 (+0.90)

Earnings Expert Research - Goldman Sachs Group
PR Newswire - Fri Oct 31, 8:10AM CDT
Investor-Edge.com has issued free earnings research on The Goldman Sachs Group Inc. (NYSE: GS). On October 16, 2014, the company reported its financial results for Q3 FY14 (period ended September 30, 2014). Click on www.investor-edge.com/FreeReports to read our free earnings review on The Goldman Sachs Group Inc. (Goldman Sachs). During Q3 FY14, the company's net revenues and net earnings surged 25% and 48%, respectively, on a Y-o-Y basis, and diluted EPS increased $1.69 from the preceding year quarter. Our free coverage report can be accessed at:
GS: 189.99 (+3.02)

'Fast Money' Recap: A Disappointing Development for Citi Investors
at The Street - Fri Oct 31, 4:00AM CDT
The trading panel discussed which banks should be your investment choice and earnings from GoPro, Starbucks and LinkedIn.
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), GS: 189.99 (+3.02), LNKD: 228.96 (+26.06), C: 53.53 (+0.38), WFC: 53.09 (+0.63), TASR: 18.84 (+1.14), TLT: 119.25 (-0.31), MBLY: 52.01 (+1.11), MS: 34.95 (+0.43)

RCS Capital Slumps: RCAP Plunges 14.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:32AM CDT
RCS Capital (RCAP) fell over 14% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 27% in the past one-month time frame.
RCAP: 16.41 (-0.24), GS: 189.99 (+3.02), GCAP: 8.56 (+1.51), MS: 34.95 (+0.43)

Conference Participation, Dividend, Upcoming Annual Meeting, Training Program, and Promotional Event - Research Reports on Santander Brasil, Goldman Sachs, Visa, Banco Santander and American Express
PR Newswire - Thu Oct 30, 7:30AM CDT
Today, Analysts Review released its research reports regarding Banco Santander Brasil SA (NYSE: BSBR), The Goldman Sachs Group Inc. (NYSE: GS), Visa Inc. (NYSE: V), Banco Santander, S.A. (NYSE: SAN) and American Express Company (NYSE: AXP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7556-100free.
SAN: 8.77 (+0.18), V: 241.43 (+4.78), GS: 189.99 (+3.02), AXP: 89.95 (+1.21), BSBR: 5.48 (-0.46)

'Fast Money' Recap: Goodbye to QE, Hello Financial Stocks
at The Street - Thu Oct 30, 4:00AM CDT
The trading panel discussed the end of quantitative easing, retail stocks and 3-D printing.
PNRA: 161.64 (-0.71), FB: 74.99 (+0.88), C: 53.53 (+0.38), NNA: 3.17 (+0.09), BAC: 17.16 (+0.13), DWA: 22.28 (+0.25), HPQ: 35.88 (+0.56), GS: 189.99 (+3.02), JPM: 60.48 (+1.09), QQQ: 101.40 (+1.38), TRN: 35.71 (+1.20), SSYS: 120.36 (+4.95), FFIV: 122.98 (+1.20), COST: 133.37 (+0.37), TRLA: 46.65 (+2.31), TWTR: 41.47 (-0.33), SNY: 46.24 (+0.54), WTW: 26.05 (+0.49)

How Businesses Can Beat the Weather
Brendan Mathews, The Motley Fool - Motley Fool - Wed Oct 29, 8:13AM CDT
Winter is coming. So now is a good time to think about weather and its effect on businesses. As a long-term investor, The Motley Fool's Brendan Mathews says he wouldn't buy or sell a stock based on random weather patterns. But weather does have a big...
GS: 189.99 (+3.02), CMG: 638.00 (-1.68), UPS: 104.91 (+1.62), BKW: 32.68 (+0.64)

'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 46.93 (-0.54), RICE: 26.43 (+1.21), GS: 189.99 (+3.02), FEYE: 33.99 (+0.36), ISIS: 46.06 (+0.18), CYBR: 35.28 (+0.57), GNC: 41.57 (-1.33), HAL: 55.14 (+1.22), EOG: 95.05 (+2.83), AGIO: 84.03 (-0.34), FTNT: 26.05 (+0.31)

Deutsche Bank Names CFO Amid Financial Reporting and Legal Troubles
at The Street - Tue Oct 28, 7:53PM CDT
The move, part of a larger management restructuring, may help ease investors' concerns on a number of fronts.
GS: 189.99 (+3.02), DB: 31.32 (+0.55)

Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game
at The Street - Tue Oct 28, 7:26PM CDT
It's expectations, not the earnings, that determine the direction of a company's stock price, and several companies proved that today, Cramer says.
KSS: 54.22 (-0.58), FEYE: 33.99 (+0.36), CYBR: 35.28 (+0.57), FB: 74.99 (+0.88), GNC: 41.57 (-1.33), HAL: 55.14 (+1.22), AGCO: 44.31 (+0.36), BWLD: 149.28 (-0.76), MAS: 22.07 (+0.27), YHOO: 46.05 (+0.42), WHR: 172.05 (+1.50), VSI: 46.93 (-0.54), SAVE: 73.11 (+2.21), RICE: 26.43 (+1.21), GS: 189.99 (+3.02), PH: 127.03 (+2.36), ISIS: 46.06 (+0.18), CMI: 146.18 (+1.56), EOG: 95.05 (+2.83), AGIO: 84.03 (-0.34), TWTR: 41.47 (-0.33), FTNT: 26.05 (+0.31), BABA: 98.60 (-0.13)

SmarTrend Watching for Potential Pullback in Shares of Goldman Sachs Group After 1.31% Gain
Comtex SmarTrend(R) - Tue Oct 28, 4:14PM CDT
Goldman Sachs Group (NYSE:GS) traded in a range yesterday that spanned from a low of $183.20 to a high of $186.32. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $184.16 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GS: 189.99 (+3.02)

Goldman Sachs Group Set to Possibly Pullback After Yesterday's Rally of 1.31%
Comtex SmarTrend(R) - Tue Oct 28, 4:14PM CDT
Goldman Sachs Group (NYSE:GS) traded in a range yesterday that spanned from a low of $183.20 to a high of $186.32. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $184.16 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GS: 189.99 (+3.02)

3 Stocks to Weather a Market Crash
Matthew Frankel, The Motley Fool - Motley Fool - Tue Oct 28, 7:31AM CDT
While the latest market sell-off turned out not to be the big "crash" that a bunch of experts have been calling for, that doesn't mean we're out of the woods just yet. Now, I don't particularly believe that we're heading for a crash anytime soon,...
V: 241.43 (+4.78), GS: 189.99 (+3.02), TD: 49.26 (+0.32), JPM: 60.48 (+1.09), AXP: 89.95 (+1.21), USB: 42.60 (+0.46), C: 53.53 (+0.38), MTB: 122.18 (+2.58), WFC: 53.09 (+0.63), BK: 38.72 (+0.75)

Goldman Sachs Recognizes Eagle Eye Networks Founder & CEO Dean Drako as One of the '100 Most Intriguing Entrepreneurs of 2014'
Business Wire - Mon Oct 27, 3:13PM CDT
Eagle Eye Networks today announced that Goldman Sachs (NYSE:GS) recognized Eagle Eye Networks founder and CEO Dean Drako as one of the 100 Most Intriguing Entrepreneurs of 2014 at its Builders + Innovators Summit in Santa Barbara, California.
GS: 189.99 (+3.02)

Interesting GS Put And Call Options For December 5th
DividendChannel.com - Mon Oct 27, 10:38AM CDT
Investors in Goldman Sachs Group Inc. saw new options begin trading today, for the December 5th expiration.
GS: 189.99 (+3.02)

The 3 Smartest Things You Can Do With Your Cash Right Now
Motley Fool Staff - Motley Fool - Sun Oct 26, 2:01PM CDT
Source: Flickr user Paul Townsend.  Stock market gyrations making your stomach churn these days? You're probably not alone, as the VIX, a measure of volatility in the broad-based S&P 500 , has doubled over the past month. However,...
GS: 189.99 (+3.02), C: 53.53 (+0.38), BAC: 17.16 (+0.13), INTC: 34.01 (+1.43)

Goldman Sachs Group (GS) Stock Research Links

GS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 184

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 262

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 192

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 427

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading